Disposable blood bag can be defined as a sterile, clear, and plastic bag used for transfer, storage, collection, and transfusion of blood and its components. The disposable blood bag consists of multiple bag interconnected with the help of tubes, clamps, needles, and needle cover. The blood bag are manufactured from bio compatible PVC materials and additives to preserve blood and its components till transfusion or further use. The global disposable blood bag market was valued at $279 million in 2016, and is estimated to reach at $580 million by 2023, registering a CAGR of 11% from 2017 to 2023. The volume of disposable blood bag market was 275 million units in 2016 and expected to reach by 556 million units by 2013, registering a CAGR of 10.5%.
Rise in surgical procedures and surge in number of trauma and accidents around the globe drive the market. Moreover, surge in incidences of various diseases is expected to boost the market growth. However, risks related to blood transfusion and low number of blood donations in underdeveloped regions impede the growth of the disposable blood bag market.
The disposable blood bag market is segmented based on product type, end user, and geography. Based on product type, it is divided into collection bag and transfer bag. By end user, the market is categorized into hospital based and standalone. By geography, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
KEY MARKET BENEFITS FOR STAKEHOLDERS
KEY MARKET SEGMENTS
By End User
KEY PLAYERS PROFILED IN THE REPORT
The other players in the value chain include (profiles not included in the report)
Cephalosporin Market by Generation (First-generation, Second-generation, Third-generation, Fourth-generation, and Fifth-generation), Type (Branded and Generics), Route of Drug Administration (Injection and Oral), and Application (Respiratory Tract Infection, Skin Infection, Ear Infection, Urinary Tract Infection, and Sexually Transmitted Infection) - Global Opportunity Analysis and Industry Forecast, 2017-2023
Cephalosporin is a group of semisynthetic, broad-spectrum antibiotics, which is majorly used to treat bacterial infections. It resembles penicillin and hence is used as an alternative for patients who are allergic to penicillin. It is used in the treatment of a variety of clinical conditions, including pneumonia, skin infections, strep ...
November 2017 | $5370 |View Details>>
The Global Drugs for Malaria market size will be XX million (USD) in 2022, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) of XX% from between 2016 and 2022. This report studies the global Drugs for Malaria market, especially in North America, Europe, Asia-Pacific, South ...
November 2017 | $4960 |View Details>>
In 2016, the Asia-Pacific Drugs for Malaria market size was xx million USD and it will reach xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. This report studies Drugs for Malaria in Asia-Pacific market, especially in China, Japan, Korea, Taiwan, India, Australia, Indonesia, Thailand and ...
November 2017 | $4660 |View Details>>
In 2016, the Drugs for Malaria market size was xx million USD in China, and it will be xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. In China market, the top players include Cipla Guilin Pharmaceutical ...
November 2017 | $3360 |View Details>>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research